Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $9.79 is 8.42% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 9.85||$ 44|
|Low:||$ 9.66||$ 9.03|
Company Description (as filed with the SEC)
At Adamas Pharmaceuticals, Inc., we seek to redefine the treatment experience for patients suffering from chronic neurological diseases. Our vision is grand, our goal bold: to create and commercialize a new generation of medicines intended to lessen the burden of disease on patients, caregivers and society. With a new commercial medicine and robust pipeline of investigational programs focused on meaningfully differentiated treatment options for patients, we believe we are well on our way. Our therapeutic targets include a broad range of neurologic diseases, including Parkinson's disease, multiple sclerosis, epilepsy and Alzheimer's disease. Our treatment innovations stem from a deep scientific understanding of time-dependent biology-the deliberate mapping of disease patterns and drug activity-along with a goal to meaningfully increase the efficacy of known molecules without compromising tolerability. ... More ...
Nasdaq Official Price
Dec. 12, 2018
Dec. 11, 2018